Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. DEF 14A Proxy Proxy Statement
  2. 8-K Event Regulation FD disclosure · Other events
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. 8-K Event Other events
  6. 8-K Event Executive or director change
  7. 8-K Event Results of operations · Executive or director change
  8. 8-K Event Other events
  9. 8-K Event Other events
  10. 8-K Event Results of operations
  11. 8-K Event Other events
  12. 8-K Event Executive or director change · Other events
  13. 8-K Event Shareholder vote results
  14. 8-K Event Results of operations
  15. DEF 14A Proxy Proxy Statement
  16. 8-K Event Material agreement · Other events
  17. 8-K Event Executive or director change
  18. 8-K Event Other events
  19. 8-K Event Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure
  20. 10-K Report Annual Report

Page 2 of 3 · 44 filings